Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Advantage Diagnostics Corp. — Predicate Candidate Screening

10 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

86 daysmedian FDA review time
116 days90th percentile
10clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K023712ADVANTAGE MULTIPLE DRUGS OF ABUSE TESTAdvantage Diagnostics Corp.2003-01-31880
K013778PEACE OF MIND HOME DRUG TESTAdvantage Diagnostics Corp.2002-02-07860
K011962ADVANTAGE MARIJUANA (THC) AND COCAINE HOME DRUG TESTAdvantage Diagnostics Corp.2001-08-09480
K010921ADVANTAGE MARIJUANA (THC) HOME DRUG TESTAdvantage Diagnostics Corp.2001-06-25900
K003708ADVANTAGE THC/COCAINE TESTAdvantage Diagnostics Corp.2001-01-22520
K001567ADVANTAGE THC TESTAdvantage Diagnostics Corp.2000-06-19310
K994227ADVANTAGE HCG TEST (URINE/SERUM)Advantage Diagnostics Corp.2000-02-03500
K991883REDI-TEST OPIATESAdvantage Diagnostics Corp.1999-09-151050
K903416CANNULA, SURGICALAdvantage Diagnostics Corp.1990-11-231160
K881369ADVANCE DIAGNOSTICS DISPOSABLE EYECUPAdvantage Diagnostics Corp.1988-05-13420

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda